Primary Research on Chinese Medicine Treatment of Androgen-Independent Prostate Cancer

被引:0
|
作者
张蜀武 [1 ]
周仕轶 [1 ]
邵继春 [1 ]
曲晓伟 [1 ]
机构
[1] Chengdu University of Traditional Chinese Medicine
关键词
In; RHD; Primary Research on Chinese Medicine Treatment of Androgen-Independent Prostate Cancer;
D O I
暂无
中图分类号
R737.25 [前列腺肿瘤];
学科分类号
摘要
Prostate cancer(PC) is a common malignant tumor in the male seniors,and its incidence has been ascending in China in recent years. Over 80%of the patients are diagnosed as being in the late stage and lose the opportunity of radical operation because of its early stage metastasis. Endocrinotherapy is regarded
引用
收藏
页码:168 / 169
页数:2
相关论文
共 50 条
  • [21] Low PSA metastatic androgen-independent prostate cancer
    Sella, A
    Konichezky, M
    Flex, D
    Sulkes, A
    Baniel, J
    EUROPEAN UROLOGY, 2000, 38 (03) : 250 - 254
  • [22] Development of the VCaP androgen-independent model of prostate cancer
    Loberg, RD
    St John, LN
    Day, LL
    Neeley, CK
    Pienta, KJ
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (02) : 161 - 168
  • [23] Proteomic Signatures of Angiogenesis in Androgen-Independent Prostate Cancer
    Karagiannis, George S.
    Saraon, Punit
    Jarvi, Keith A.
    Diamandis, Eleftherios P.
    PROSTATE, 2014, 74 (03): : 260 - 272
  • [24] Alternatives to death: Understanding androgen-independent prostate cancer
    Joel B. Nelson
    Nature Medicine, 1998, 4 : 1011 - 1012
  • [25] Signal Transduction Targets in Androgen-independent Prostate Cancer
    Jian Zhou
    Jessica Scholes
    Jer-Tsong Hsieh
    Cancer and Metastasis Reviews, 2001, 20 : 351 - 362
  • [26] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    Beer, TM
    Garzotto, M
    Henner, WD
    Eilers, KM
    Wersinger, EM
    BRITISH JOURNAL OF CANCER, 2003, 89 (06) : 968 - 970
  • [27] Alternatives to death: Understanding androgen-independent prostate cancer
    Nelson, JB
    NATURE MEDICINE, 1998, 4 (09) : 1011 - 1012
  • [28] Chemosensitization of androgen-independent prostate cancer with neutral endopeptidase
    Sumitomo, M
    Asano, T
    Asakuma, J
    Asano, T
    Nanus, DM
    Hayakawa, M
    CLINICAL CANCER RESEARCH, 2004, 10 (01) : 260 - 266
  • [29] Intermittent chemotherapy in metastatic androgen-independent prostate cancer
    T M Beer
    M Garzotto
    W D Henner
    K M Eilers
    E M Wersinger
    British Journal of Cancer, 2003, 89 : 968 - 970
  • [30] Current chemotherapeutic approaches for androgen-independent prostate cancer
    Rumohr, Jon A.
    Chang, Sam S.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (06) : 529 - 533